1. Home
  2. APLM vs GBR Comparison

APLM vs GBR Comparison

Compare APLM & GBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APLM
  • GBR
  • Stock Information
  • Founded
  • APLM 2016
  • GBR 1978
  • Country
  • APLM United States
  • GBR United States
  • Employees
  • APLM N/A
  • GBR N/A
  • Industry
  • APLM Blank Checks
  • GBR Oil & Gas Production
  • Sector
  • APLM Finance
  • GBR Energy
  • Exchange
  • APLM Nasdaq
  • GBR Nasdaq
  • Market Cap
  • APLM 6.1M
  • GBR 5.2M
  • IPO Year
  • APLM N/A
  • GBR N/A
  • Fundamental
  • Price
  • APLM $18.43
  • GBR $1.10
  • Analyst Decision
  • APLM
  • GBR
  • Analyst Count
  • APLM 0
  • GBR 0
  • Target Price
  • APLM N/A
  • GBR N/A
  • AVG Volume (30 Days)
  • APLM 89.6K
  • GBR 279.3K
  • Earning Date
  • APLM 09-30-2025
  • GBR 11-12-2025
  • Dividend Yield
  • APLM N/A
  • GBR N/A
  • EPS Growth
  • APLM N/A
  • GBR N/A
  • EPS
  • APLM N/A
  • GBR N/A
  • Revenue
  • APLM $198,000.00
  • GBR $151,000.00
  • Revenue This Year
  • APLM $415.15
  • GBR N/A
  • Revenue Next Year
  • APLM N/A
  • GBR N/A
  • P/E Ratio
  • APLM N/A
  • GBR N/A
  • Revenue Growth
  • APLM N/A
  • GBR 4.14
  • 52 Week Low
  • APLM $3.66
  • GBR $0.67
  • 52 Week High
  • APLM $35.98
  • GBR $1.78
  • Technical
  • Relative Strength Index (RSI)
  • APLM 90.29
  • GBR 56.29
  • Support Level
  • APLM $3.66
  • GBR $0.95
  • Resistance Level
  • APLM $6.37
  • GBR $1.26
  • Average True Range (ATR)
  • APLM 1.65
  • GBR 0.09
  • MACD
  • APLM 1.20
  • GBR 0.01
  • Stochastic Oscillator
  • APLM 85.30
  • GBR 48.39

About APLM Apollomics Inc.

Apollomics Inc is an clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia.

About GBR New Concept Energy Inc

New Concept Energy Inc is a United States-based company engaged in Real Estate Operations. It intends to continue to operate and or sell its West Virginia property. It provides advisory and management services for an independent West Virginia oil and gas company. The Company seeks to establish or acquire new business operations. It operates in one segment, which is real estate rental.

Share on Social Networks: